Michaelson Jennifer (CIK 0001838061)

Latest company ownership

Role: Chief Scientific Officer
Shares held
138,004
Last filed at
Nov 25, 2025
Confidence Score
21.8
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 19, 2025 Dec 22, 2025 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 48.1 -1,345 -1.00% $13.5K
Dec 18, 2025 Dec 19, 2025 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 26.3 -2,898 -2.12% $28K
Dec 12, 2025 Dec 16, 2025 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -3,143 -2.24% $38.4K
Nov 24, 2025 Nov 25, 2025 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -4,000 -2.82% $49.2K
Feb 25, 2025 Feb 27, 2025 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 26.3 -3,756 -2.58% $32K
Jan 6, 2025 Jan 7, 2025 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 37.5 -4,000 -4.01% $50K
Dec 18, 2024 Dec 20, 2024 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 22.5 -4,693 -4.49% $53.5K
Dec 12, 2024 Dec 16, 2024 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 26.3 -3,489 -3.23% $43.7K
Nov 5, 2024 Nov 7, 2024 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 32.5 -8,000 -6.90% $125.1K
Sep 5, 2024 Sep 9, 2024 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 32.5 -8,000 -6.45% $144.7K
Jul 5, 2024 Jul 9, 2024 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 32.5 -8,000 -6.06% $130.6K
May 6, 2024 May 8, 2024 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 20.0 -63,606 -13.46% $1.8M
Dec 21, 2023 Dec 22, 2023 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 27.5 -1,145 -1.29% $9.7K
Dec 18, 2023 Dec 20, 2023 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -238 -0.27% $2K
Dec 12, 2023 Dec 13, 2023 Cullinan Therapeutics, Inc. Chief Scientific Officer Sell 27.5 -1,068 -1.19% $8.3K
Jun 20, 2023 Jun 21, 2023 Cullinan Therapeutics, Inc. Chief Development Officer Sell 45.0 -238 -0.26% $3.1K
Jun 12, 2023 Jun 14, 2023 Cullinan Therapeutics, Inc. Chief Development Officer Sell 52.5 -176 -0.19% $2.3K
Jun 6, 2023 Jun 8, 2023 Cullinan Therapeutics, Inc. Chief Development Officer Sell 32.5 -12,000 -6.22% $147.7K
May 18, 2023 May 19, 2023 Cullinan Therapeutics, Inc. Chief Development Officer Sell 45.0 -239 -0.26% $2.1K
May 12, 2023 May 16, 2023 Cullinan Therapeutics, Inc. Chief Development Officer Sell 45.0 -193 -0.21% $1.7K
Apr 18, 2023 Apr 20, 2023 Cullinan Therapeutics, Inc. Chief Development Officer Sell 45.0 -238 -0.26% $2.5K
Apr 12, 2023 Apr 14, 2023 Cullinan Therapeutics, Inc. Chief Development Officer Sell 52.5 -176 -0.19% $1.8K
Mar 20, 2023 Mar 27, 2023 Cullinan Therapeutics, Inc. Chief Development Officer Sell 45.0 -238 -0.26% $2.7K
Nov 25, 2022 Nov 29, 2022 Cullinan Therapeutics, Inc. Officer Sell 32.5 -4,000 -7.01% $53.2K
Sep 27, 2022 Sep 29, 2022 Cullinan Therapeutics, Inc. Officer Sell 36.3 -4,000 -7.01% $49.6K
Aug 8, 2022 Aug 9, 2022 Cullinan Therapeutics, Inc. Chief Development Officer Sell 45.0 -1,385 -2.55% $20.8K
Jul 25, 2022 Jul 26, 2022 Cullinan Therapeutics, Inc. Chief Development Officer Sell 25.0 -8,000 -13.11% $116.1K
Oct 18, 2021 Oct 20, 2021 Cullinan Therapeutics, Inc. Officer Sell 25.0 -4,000 -14.86% $85.7K
Sep 20, 2021 Sep 21, 2021 Cullinan Therapeutics, Inc. Officer Sell 25.0 -4,000 -14.86% $98K
Aug 18, 2021 Aug 26, 2021 Cullinan Therapeutics, Inc. Officer Sell 25.0 -4,000 -14.86% $110.6K
Aug 18, 2021 Aug 24, 2021 Cullinan Therapeutics, Inc. Officer Sell 22.5 -4,000 -14.86% $110.6K